Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121332267 | 12133226 | 7 | F | 20160701 | 20160711 | 20160301 | 20160725 | EXP | GB-ALEXION PHARMACEUTICALS INC-A201600442 | ALEXION | 39.73 | YR | F | Y | 0.00000 | 20160725 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121332267 | 12133226 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | UNK UNK, QW | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||||||
| 121332267 | 12133226 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | P0003801 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 121332267 | 12133226 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | P0004002 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 121332267 | 12133226 | 4 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | P0004102 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 121332267 | 12133226 | 5 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | P0004707 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 121332267 | 12133226 | 6 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | P0004603 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 121332267 | 12133226 | 7 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | P0004801 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 121332267 | 12133226 | 8 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | 0 | |||||||||||
| 121332267 | 12133226 | 9 | C | PENICILLIN V /00001801/ | PENICILLIN V | 1 | Unknown | 0 | |||||||||||
| 121332267 | 12133226 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121332267 | 12133226 | 1 | Paroxysmal nocturnal haemoglobinuria |
| 121332267 | 12133226 | 8 | Product used for unknown indication |
| 121332267 | 12133226 | 9 | Product used for unknown indication |
| 121332267 | 12133226 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121332267 | 12133226 | OT |
| 121332267 | 12133226 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121332267 | 12133226 | Abdominal pain | |
| 121332267 | 12133226 | Cholelithiasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121332267 | 12133226 | 1 | 20110531 | 0 | ||
| 121332267 | 12133226 | 2 | 20110531 | 0 | ||
| 121332267 | 12133226 | 3 | 20110531 | 0 | ||
| 121332267 | 12133226 | 4 | 20110531 | 0 | ||
| 121332267 | 12133226 | 5 | 20110531 | 0 | ||
| 121332267 | 12133226 | 6 | 20110531 | 0 | ||
| 121332267 | 12133226 | 7 | 20110531 | 0 |